The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-1-((5-Benzyl-2-hydroxybenzyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)-1-oxopropan-2-aminium Trifluoroacetate ID: ALA4475106
PubChem CID: 155537458
Max Phase: Preclinical
Molecular Formula: C27H29F3N2O5
Molecular Weight: 404.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(O)cc(C)c1C[C@H](N)C(=O)NCc1cc(Cc2ccccc2)ccc1O.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C25H28N2O3.C2HF3O2/c1-16-10-21(28)11-17(2)22(16)14-23(26)25(30)27-15-20-13-19(8-9-24(20)29)12-18-6-4-3-5-7-18;3-2(4,5)1(6)7/h3-11,13,23,28-29H,12,14-15,26H2,1-2H3,(H,27,30);(H,6,7)/t23-;/m0./s1
Standard InChI Key: MTPLPYUPPUKOPG-BQAIUKQQSA-N
Molfile:
RDKit 2D
37 38 0 0 0 0 0 0 0 0999 V2000
43.2286 -10.1612 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
43.9363 -9.7526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6440 -10.1612 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
43.9302 -10.5657 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
43.9393 -8.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6486 -8.5295 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.2332 -8.5242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.9776 -8.4773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9764 -9.2968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6845 -9.7058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3941 -9.2964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3913 -8.4737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6827 -8.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0975 -8.0624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8067 -8.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8064 -9.2832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5149 -9.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2220 -9.2777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2163 -8.4563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5073 -8.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9210 -8.0426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6317 -8.4460 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3364 -8.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0470 -8.4357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8673 -8.0219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5202 -8.4254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3304 -7.2151 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.5214 -9.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2313 -9.6453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9369 -9.2315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9283 -8.4101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2179 -8.0105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2081 -7.1933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6482 -9.6340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.0530 -9.1951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8154 -9.7113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9318 -9.6827 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
2 5 1 0
5 6 2 0
5 7 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
19 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
23 27 2 0
26 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 26 1 0
32 33 1 0
30 34 1 0
24 35 1 6
28 36 1 0
18 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.51Molecular Weight (Monoisotopic): 404.2100AlogP: 3.49#Rotatable Bonds: 7Polar Surface Area: 95.58Molecular Species: NEUTRALHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.23CX Basic pKa: 8.03CX LogP: 4.46CX LogD: 3.98Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.48Np Likeness Score: 0.13
References 1. Henry SP, Fernandez TJ, Anand JP, Griggs NW, Traynor JR, Mosberg HI.. (2019) Structural Simplification of a Tetrahydroquinoline-Core Peptidomimetic μ-Opioid Receptor (MOR) Agonist/δ-Opioid Receptor (DOR) Antagonist Produces Improved Metabolic Stability., 62 (8): [PMID:30924650 ] [10.1021/acs.jmedchem.9b00219 ]